May 10, 2021, News Coverage
Our PCM Trials division was featured in the Denver Business Journal for the remarkable growth and positive impact on the clinical research industry. During the pandemic our entire team has done great work on many fronts – sustaining trial continuity for our biopharmaceutical customers, advancing our technology platforms, and providing advanced solutions to take clinical trials to patients’ homes.
The Trials team has stretched in the past year to extend services in a number of new ways. While we’ve always been flexible to the needs of our customers, we strived to go above and beyond during the pandemic. We have made a difference in the lives of many, leading to broader adoption of decentralized clinical trials and a lasting impact in the research of life-improving drugs and therapies.
Read the Denver Business Journal Full Article